<DOC>
	<DOCNO>NCT02183506</DOCNO>
	<brief_summary>Investigate bioavailability BI 1356 BS metformin concomitant multiple oral administration 10 mg BI 1356 BS tablet 3 x 850 mg metformin comparison BI 1356 BS metformin give alone</brief_summary>
	<brief_title>Bioavailability BI 1356 BS Metformin After Co-administration Compared Bioavailability BI 1356 BS Alone Metformin Alone Healthy Male Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Healthy male accord follow criterion , base upon complete medical history , include physical examination , vital sign ( blood pressure ( BP ) , pulse rate ( PR ) ) , 12lead electrocardiogram ( ECG ) , clinical laboratory test No find deviate normal clinical relevance No evidence clinically relevant concomitant disease Age ≥ 21 Age ≤ 50 year BMI ( Body Mass Index ) ≥ 18.5 ≤ 29.9 kg/m2 Ability give sign dated write informed consent prior admission study accordance good clinical practice ( GCP ) local legislation Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial investigator Intake drug long halflife ( &gt; 24 hour ) within one month le 10 halflives respective drug prior administration conduct trial ( review clinical monitor question ) Use drug might reasonably influence result trial ( base knowledge time protocol preparation ) within 10 day prior administration conduct trial Participation another trial investigational drug within two month prior administration conduct trial Smoker ( 10 cigarette 3 cigar 3 pipe per day ) Inability refrain smoke conduct trial Alcohol abuse ( 60 g/day ) Drug abuse Blood donation ( 100 mL within four week prior administration conduct trial ) Excessive physical activity ( within one week prior administration conduct trial ) Any laboratory value outside normal reference range clinical relevance Inability comply dietary regimen study center No adequate contraception ( condom use plus another form contraception e.g. , spermicide , oral contraceptive take female partner , sterilization ) whole study period time first intake study drug one month last intake drug</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>